9. Oral Cancer and Precancer Flashcards

1
Q

Oral squamous cell carcinoma (OSCC) and Oropharyngeal SCC

• 51,540 new cases in 2018
- 3.0 % of all new cancers
• 10,030 deaths in 2018
- >____ death per hour every day
• Incidence rates >2x higher in ____ than women
• 1.2% of population will be diagnosed in lifetime

• 5-year survival rates (2008-2014)
– Overall
– Early diagnosis (Stages \_\_\_\_)
– Late diagnosis (Stages \_\_\_\_)
• Late diagnosis accounts for over \_\_\_\_% of all diagnoses
– African-American 33%
– Caucasian \_\_\_\_%

• The biggest hurdle in improving 5-year survival rates is ____ and ____!

• Posterior boundary of oral cavity > PG folds
	○ From the \_\_\_\_ to the \_\_\_\_ folds
• Anterior boundary of oropharynx > PP folds
	○ \_\_\_\_(tonsils) are located within the oropharyngeal region
• No sex predilection, but more prevalent in \_\_\_\_
• Talking about cancer - 5 yr survival rates - "what are my chances?"
	○ The rates guide \_\_\_\_ and \_\_\_\_ over many patients
	○ 5 years from time of finishing diagnosis - whether the cancer recurs, whether they get new cancer, or whether the patient dies/lives
• 65% - in the realm of OK survival rates
• Most carcinomas use the TMN staging system
	○ Subcategorize into I-IV stages
	○ IV - the worse the prognosis
• Ethnic variations - \_\_\_\_ have worse survival rate than Caucasians
• Early diagnosis and prevention is critical
A
1
men
I & II
III & IV
60
55

awareness
early diagnosis

lips
PG

adenoids
males

treatment
prognosis

AA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Age of onset Median age = ____

Age of death Median age = ____

____% - Localized to primary site
____% - Spread to regional lymph nodes
____% - Cancer has metastasized
4% - Unknown

• Oropharyngeal cancer
	○ After the age of 55 - primarily an older person's disease
	○ From 20-54 - 25% of patients will get cancer [???]
	○ Ones who get cancer at a younger age have a better \_\_\_\_ (only 15% of the 25% will die of the disease under 55)
		§ This applies to all cancer types
• At time of diagnosis: 
	○ 30% cancer localized to one area (I or II)
		§ Implies that \_\_\_\_% of all cancers will have already spread to other sites/lymph nodes
	○ Most oropharyngeal cancers are diagnosed \_\_\_\_ - which is what contributes to these numbers
• Oropharynx spread - not a metastasis - considered to be \_\_\_\_ primary cancer if it's a different site
A
63
67
30
47
19

prognosis
70
late
secondary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology of OSCC
• >90% occur in patients >____ yrs
• Increasing incidence in ____ patients (<40 yrs) without risk factors
• Ethnic and racial variation in survival not ____
– May reflect access to healthcare, level of education, and late diagnosis

• OSCC - implying we're talking about only oral cancer
	○ Very different from oropharyngeal cancer
• First number - both OSCC and oropharyngeal; the second number is for \_\_\_\_ only
• We assumed increasing incidence was due to \_\_\_\_ for OSCC, but it's not; IT DOES NOT CAUSE THIS TYPE OF CANCER
	○ For oropharyngeal it is because of \_\_\_\_
A

50
younger
prevalence

OSCC

HPV
HPV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
The facts
• Litigation against dentists is frequently related to oral cancer
– Failure to \_\_\_\_
– Misdiagnosis
– Inappropriate \_\_\_\_ dentistry
• Oral cancer awareness is increasing
• Ultimate goal of cancer treatment is \_\_\_\_
• Need for appropriate 
– \_\_\_\_
– Detection
– \_\_\_\_
– Diagnosis
• Post-therapeutic needs: rampant \_\_\_\_, xerostomia - it's the dentist's responsibility to treat these manifestations, not the oncologist
A
diagnose
post-therapeutic
prevention
education
recognition
caries
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

OSCC is a multifactorial disease

Extrinsic factors
\_\_\_\_ / smoking / smokeless tobacco 
\_\_\_\_
Ultraviolet light
\_\_\_\_ nut
Sanguinaria
Psychoactive plants

Intrinsic factors
____ / epigenetics Genomic instability Chronic immunosuppression
Previous history of OSCC

• Multifactorial - both extrinsic and intrinsic factors Extrinsic factors
• Smoking and chronic alcohol usage are the most common factors for \_\_\_\_-development and involved with oropharyngeal (but the biggest factor is \_\_\_\_)
	○ Smokeless tobacco to replace cigarette smoking - some forms of it may increase risk of cancer, however
	○ Can suggest usage - the risk is \_\_\_\_ but not absent entirely
• UV light a risk factor for the \_\_\_\_ lip
• Betel nut - naturally occurring substance > addictive, reddish coloration, contains a carcinogen > increases risk of OSCC
• Sanguinaria and psychoactive plants - addictive and carcinogenic

Intrinsic factors
• These apply for all ____
• Long ____ - less of a cancer risk
• ____ (chronic immunosuppression) - secondary risk for OSCC

A
tobacco
alcohol
betel
genetics
OSCC
HPV
lower
lower
cancers
telomeres
cyclosporine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

≥ 80% of all OSCC caused by tobacco / alcohol

• Smoking
– Active and passive
– ____x risk

• Alcohol
– Increases risk ____x

• Synergism
– >5 drinks/day + >20 cigs/day =
>____x increased risk than either alone
– >____x risk over non-smokers and drinkers

• Field cancerization

• Do not memorize any numbers - just the trends (stages)
• Smoking has the highest risk of any factors for OSCC-development
	○ No evidence that second hand smoke causes OSCC, but it may for \_\_\_\_ and certainly lung cancer
• \_\_\_\_ drinking can be a risk for some patients
• Previous smokers can have a lower risk than a current smoker, but still have higher risk than a never smoker
	○ Smoking causes damage to DNA > propagated during cell division to yield new cells that contain the same damage > eventually, so much damage in DNA in one cell > allows the cell to proliferate uncontrollably
	○ Field cancerization [???] - one cell exposed is all cells exposed in organ sites - i.e. bronchioles down to your lungs will be exposed to carcinogens
		§ All \_\_\_\_ are affected somewhat equally
		§ Patient with cancer on buccal mucosa is equally likely to occur at another area
A

8-20
6
13
50

oropharyngeal
social
areas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

• Sun damaged skin - ____
○ Blue stain - ____ fibers
○ Can occur in any area - field cancerization effect

A

solar elastosis

elastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ethnic customs

• Betel nut (Areca nut)
– Commonly used in South and East ____

• Bidi
– Rudimentary, hand-rolled ____

• Yerba mate
– Ilex ____

• Toombak
– ____ snuff

• Khat / Qat
– ____ plant

  • Shisha / Hooka (Water pipe)
    • Yerba mate - ____ cancer is common (South America)
A
asia
cigarette
paraguayensis
sudanese
catha edulis
esophageal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Intrinsic factors
• Not everyone who smokes or drinks develops OSCC
• Young age of onset almost always associated with inherent ____
• Increased risk by 2-4 fold if positive family history
– 1 or more ____ degree relatives affected

• Intrinsic factors further modify the risk of any given patient
• OSCC is not a \_\_\_\_ inherited cancer
	○ There is a risk if you have a first degree relative with cancer
A

predisposition
first
genetically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Intrinsic factors

• Genetic \_\_\_\_
• Short \_\_\_\_
• Chronic immunosuppression
– \_\_\_\_ patients on medications 
– Severe \_\_\_\_ deficiency
• Telomeres are inheritable
A

polymorphisms
telomeres
transplant
iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q
Genetic diseases associated with OSCC development
• Fanconi anemia
• Dyskeratosis congenita
• Li-Fraumeni syndrome
• Ataxia telangiectasia
• Bloom syndrome
• Xeroderma pigmentosum
• Epidermolysis bullosa
• The risk for cancer is transferrable
• XP (middle patient) > has \_\_\_\_ cancer but has a risk for OSCC
• EB (BR patient)
	○ \_\_\_\_ why it causes OSCC
• What unifies all the other diseases (1-6) -  characterized by mutations in proteins that regulate response to repair \_\_\_\_ > DNA becomes genomically unstable
A

skin
unknown
DNA damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Possible risk factors?? More research is needed

• Lichen planus
– WHO-recognized ____ lesion
– No definitive well-controlled studies that indicate risk

• ____
– Increasing number of studies suggest elevated risk

• Systemic sclerosis
– Increased risk for ____ cancer

• ____
– Some studies suggest possible risk

• LP - if left untreated can result in cancer
A

precancerous
diabetes mellitus
tongue
marijuana

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q
What does OSCC look like?
\_\_\_\_ 
Leukoplakia 
Erythroplakia 
\_\_\_\_
* Important slide
* OSCC can look like \_\_\_\_
A

non-healing ulcer
mass
anything

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

• Leukoplakia
– White lesion that does not ____ off and cannot be characterized as other pathology

• Erythroplakia
– ____ lesion that cannot be attributed to other pathology

• Erythroplakia - not \_\_\_\_ in origin and not \_\_\_\_
A

rub
red
vascularized
inflamed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does oral pre-cancer look like?
____
____

* You also treat at this \_\_\_\_
* Patients with erythroplakia - more likely to be \_\_\_\_ than leukoplakias
A

leukoplakia
erythroplakia
stage
cancerous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

• Bottom left - mass - it’s not precancerous (or dysplastic); it is either ____, reactive or ____

A

benign

cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Pre-cancerous & cancerous lesions have NO distinctive

____ features

A

clinical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Treatment Options
• Complete ____
• ____ red/white lesions in high risk areas should be excised
• Long-term ____

* \_\_\_\_ tongue - higher risk - more likely to not be seen quickly
* \_\_\_\_ of the mouth - higher risk
* [???]
* If not cancerous in high risk area > still requires \_\_\_\_
A
removal
all
follow up
posterior
floor
excision
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
Definitions
• Hyperplasia
– Increased \_\_\_\_ of cells
• Hyperkeratosis
– Increased \_\_\_\_
• Dysplasia
– \_\_\_\_ stage
– Only applies to \_\_\_\_
• Carcinoma
– Cancer of \_\_\_\_ cells
• Hyperplasia and hyperkeratosis are not \_\_\_\_ diagnoses
	○ However, if in high risk area - warrants excision
• Dysplasia used only in context of \_\_\_\_ (squamous, glandular, etc.)
A
number
keratin
pre-cancerous
epithelium
epithelial
pre-cancerous
epithelium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Carcinogenesis arises from accumulation of ____ resulting in stepwise progression of normal mucosa to invasive SCC

• Changes at the \_\_\_\_  level
	○ Mutations, amplifications of oncogenes, loss of TSGs, loss of cell cycle control and inability to regulate survival (via apoptosis)
• [NOTES]
A

genetic changes

molecular

21
Q

Molecular changes

• Mutations in proto-oncogenes / tumor suppressors
– ____, p53
– DNA damage ____

• Genomic amplification
– ____ receptor
– ____

• Epigenetic changes
– ____ DNA modifications
– ____ DNA and RNA including microRNAs

  • ____ activation
    • Genomic instability is a hallmark of cancer - regardless of the cancer type
A

p16
regulators

epidermal growth factor
cyclin D1

post-translational
non-coding

telomerase

22
Q

Only five genetic alterations needed to induce epithelial transformation

  • Overexpression of ____
  • Inactivation of ____
  • Overexpression of ____
  • Overexpression of ____
  • ____ activation• In vitro - induce artificial changes to induce transformation
A
cyclin D1
p53
EGFR
c-MYC
telomerase
23
Q
Cytologic features of dysplasia
• Hyperchromatic nuclei
• Pleomorphism
• Increase nuclear : cytoplasmic ratio
• Dyskeratosis
• Mitoses
• Dysplasia - precancer/premalignancy
	○ Varying degrees - mild, moderate, severe and carcinoma in situ; to SSC
• All dysplasias have the same cytological features (the same changes to the actual dysplastic cells):
	○ Dark nuclei (hyperchromatic nuclei)
		§ Picking up more \_\_\_\_ - implying there's more active DNA
	○ Different size/shaped nuclei (pleomorphism)
		§ Naturally, epithelial cells increase in size, nucleus increases and the nucleus becomes flatters as they differentiate - within each layer!
		§ In slide, all nuclei look much darker, and are different in shape
	○ Increased nuc:cyto ratio
		§ A normal cell has a \_\_\_\_ ratio (cyto is synonymous with cell size)
		§ In dysplasia, the ratio increases to \_\_\_\_
	○ Dyskeratosis
		§ Expressing more \_\_\_\_ expression within the cell
			□ IF proteins that maintain architecture of the cell
			□ So the cells look more pink \_\_\_\_ than normal cells
	○ Mitoses
		§ Normally seen only in the \_\_\_\_ layer in epithelium
		§ In dysplasia, you see mitoses above the basal layer
			□ Cell cycle has been perturbed, apoptosis has been perturbed
A
HA
1:3
1:1
cytokeratin
cytoplasmically
basal
24
Q
Architectural features of dysplasia
• Elongated rete pegs
• Up to 1/3 = \_\_\_\_
• Up to 2/3 = \_\_\_\_
• Above 2/3 = \_\_\_\_
• Full thickness = \_\_\_\_
• Mild, moderate, severe, vs carcinoma - architectural distinction
	○ Look at rete pegs, and division to 3 sections: lower, mid and upper third
• Rete pegs are \_\_\_\_ in dysplasia - more cells within the epithelium
• Look to see where the cytological changes are found
• Carcinoma in situ does not imply cancer, but rather a \_\_\_\_
	○ Not all severe dysplasia are carcinoma in situs, but all carcinoma in situs are \_\_\_\_
	○ Treated the exact same way - a \_\_\_\_ distinction
A
mild
moderate
severe
carcinoma in situ
longer
dysplasia
severe dysplasia
semantic
25
Q

Epithelial hyperplasia and hyperkeratosis

• Small leukoplakia on lateral tongue
• Biopsy reveals hyperplasia, with parakeratosis or orthokeratosis
	○ Keratin pattern is \_\_\_\_
	○ This is not cancer, but can progress to cancer if untreated (especially with risk factors)
		§ Rubbing off broken cusp - won't \_\_\_\_; but if \_\_\_\_ - it may
A

irrelevant
progress
smoking/drinking

26
Q

Epithelial Dysplasia, Mild
• Leukoplakia
• Mild dysplasia
○ The changes induce longer rete pegs - take on a test tube shape architecturally
○ Pleomorphy, mitoses, etc. above the basal layer
§ Confined to the lower third
§ Above lower third - all nuclei look the same
□ As the cells mature, they regain the ability to ____ themselves
□ Haven’t lost all ability to ____ themselves

A

control

regulate

27
Q

Epithelial Dysplasia, Moderate

* If lose ability to \_\_\_\_ > moderate dysplasia
* Dark nuclei adjacent to cells with normal architecture in the middle 2/3
A

self-regulate

28
Q

Epithelial Dysplasia, Severe / Carcinoma in situ

• \_\_\_\_ is still intact - the changes are all confined to within the epithelium - this is why it's still \_\_\_\_
	○ May have taken 1-1000 mutations to reach this stage, but didn't develop in a mutation to allow cells to progress past the BM
A

basement membrane

pre-cancerous

29
Q

• Once invasion past BM - ____
○ Non-healing ulceration, small leukoplakia, large mass
○ Only applies to carcinomas (sarcomas don’t have ____!)
○ Can skip dysplastic stages, straight to carcinoma
○ It can also ____ backwards as well

A

squamous cell carcinoma
BM
regress

30
Q

Squamous cell carcinoma
• Severe dysplasia - unlikely for it to regress back to anything but ____; more likely to progress to ____
• Presence of tumor islands invading into the ____ tissue
○ Can go anywhere it wants - can go into BV/LV resulting in metastasis, or bone, salivary glands, mucosa, etc
§ Organs heavily vascularized (____, brain, ____) is most likely where it will metastasize to

A
moderate
SCC
connective
bone
liver
31
Q
Cytologic features of carcinoma
• Hyperchromatic nuclei
• Pleomorphism
• Increase nuclear : cytoplasmic ratio
• Dyskeratosis
• Mitoses
• \_\_\_\_
Architectural features of carcinoma
• Invasion beyond the \_\_\_\_ 
• \_\_\_\_
• Invasion into adjacent \_\_\_\_
• \_\_\_\_
• All defining features of dysplasia is what we use to define carcinomas
	○ Both the cell and nuclei are pleomorphic
• In addition, anaplasia is applied to carcinoma
	○ Poorly \_\_\_\_ cell
		§ Dysplastic cells aren't anaplastic
		§ Can look at cell, and cannot predict the cell's \_\_\_\_
	○ Not all cancers are \_\_\_\_!
• All carcinomas exhibit the architectural features
	○ Invasion beyond the BM
	○ Keratin pearls
		§ Cancers that look like the cell of \_\_\_\_ - well differentiated SCC - produce \_\_\_\_ produce within tumor islands
		§ Not common to all carcinomas - only \_\_\_\_ SCC
			□ Because \_\_\_\_ cells produce keratin, other cell types do not develop (not in prostrate, breast, or colon cancers)
	○ All carcinomas invade adjacent tissues and all have the propensity to metastasize \_\_\_\_, colon, \_\_\_\_, melanomas have high chances to metastasize
A
anaplasia
BM
keratin
tissues
metastasis

differentiated
origin
anaplastic

origin
keratin
well-differentiated
squamous
prostate
breast
32
Q

• Well-differentiated OSCC
○ ____ invading deep in connective tissue
○ Pink, globular structures - ____; and the presence of squamous cells

• Poorly-differentiated SCC
	○ Cannot tell they're \_\_\_\_
	○ Do additional tests to figure it out
		§ \_\_\_\_ - stain tissue with antibodies to proteins the cells express:
			□ \_\_\_\_ - if they don't express, can be a leukemia, \_\_\_\_, etc.
	○ Highly pleomorphic, and anaplastic (very poorly differentiated)

• Moderately-differentiated SCC
	○ Look like \_\_\_\_ in origin, but the cells don't produce \_\_\_\_
A

tumor islands
keratin pearls

squamous
immunohistochemistry
cytokeratins
lymphoma

squamous
keratin

33
Q

Histopathologic grade
• Has no bearing on ____

• Grading is strictly a \_\_\_\_ parameter - not a clinical parameter
	○ Has no bearing on prognosis
		§ A patient who has a poorly differentiated tumor may respond better than a patient with a well differentiated tumor; and vice-versa
A

prognosis

microscopic

34
Q

linical Staging
• TNM classification
– Tumor size and invasion into adjacent anatomic structures
– Presence / absence of locoregional positive lymph nodes
– Presence / absence of distant metastasis

• Modalities used:
– \_\_\_\_ exam
– \_\_\_\_ or PET/CT scan
– \_\_\_\_
– \_\_\_\_
• Clinical staging - guides how to approach therapy and our own ability to predict prognosis
• For SCC - use the TNM classification (T = tumor size, N = presence/absence of lymph nodes, M = distant metastasis)
	○ Each letter has subcategories (0-4)
		§ T0 - nothing, not a tumor; not used clinically
		§ T1 - used clinically; implies that a tumor is
A
clinical
CT
surgery
histopathology
2
multidisciplinary
35
Q

• Work-up is to yield parameters - TNM - to help guide approach to treatment
• T
○ T0 - not used
○ T1 - ____ cm
○ T4 - irrespective of size, has invaded locally into adjacent structure, or regionally distant
• The higher the number, the worse the prognosis
○ If N and M is 0, but T1 or T2 - stage 1 or stage 2
§ Good prognosis
○ And so on, increase T and prognosis gets worse
• N
○ N0 - no lymph nodes positive for cancer
○ As soon as have one lymph - N1 - stage ____
○ N2, N3 - stage ____
• M
○ M0 - no distant sites affected
○ M1 - there are distant sites affected - stage ____
• Lymph nodes are assessed by radiology - and they’re found within five areas in the H+N
○ As soon as one lymph node is suspicious for cancer - ____, and remove soft tissue and lymph nodes
• Presence of lymph nodes are assesed by ____ exam
○ ____ enlargements - could indicate lymph nodes that are positive for cancer

A

2
2-4
4

3
4
4

neck dissection
clinical
fixed

36
Q

• More ____, use of CAT scans/radiographs
○ A certain size of lymph nodes
§ ____cm in diameter; anything more than that the lymph node needs to be assessed surgically and microscopically

A

diagnostically

1.5

37
Q

Positron Emission Tomography (PET) / Computerized Tomography (CT)

• Very \_\_\_\_ technique
	○ Inject a radioactive isotope conjugated to glucose
		§ \_\_\_\_
	○ Taken up by all cells in body - most ends up in \_\_\_\_, but any cancer in order to survive needs energy and glucose
		§ Cancer cells need more \_\_\_\_ to sustain survival
		§ Lateral neck indicates a positive lymph node
• Used to highlight tumor and to highlight the lymph nodes that may be positive
A

sensitive
18-F-deoxyglucose
brain
glucose

38
Q

• Take out lymph nodes in five levels
○ [NOTES]
• Look for important landmarks: ____ carotid, ____, VII and ____
○ Remove all the ____ that’s between all the structures
○ Indicate with sutures to orient where the resection was in the patient’s body
○ Squish the tissue against table, and feel for bumps/nodules > lymph nodes
○ Fix and process them for microscopy

A

jugular
XI
SCM
fat tissue

39
Q

Presence of lymph node metastasis?

Always at least Stage ____ cancer

• Lymph nodes with no tumor - N0
• If any lymph nodes has a tumor - N1 at least, and if more than one and then on opposite side can be N2 or N3
	○ This slide shows cancer within a lymph node
• Any N status is stage \_\_\_\_; it is stage \_\_\_\_ if more than N1
A

III
3
4

40
Q

Presence of distant metastasis?
Always Stage ____ cancer

* Full body scan for other sites
* If found > M1 > stage 4 cancer
A

IV

41
Q

Oropharyngeal SCC is a multifactorial disease

Extrinsic factors
\_\_\_\_ / smoking / smokeless tobacco 
Alcohol
\_\_\_\_ nut
\_\_\_\_**

Intrinsic factors
Genetics / epigenetics Genomic instability Chronic immunosuppression
Previous history of OPSCC

* \_\_\_\_ is one of most important risk factors for oropharyngeal, not oral cancer
* The same \_\_\_\_ factors play the same role in all cancers
A
tobacco
betel
human papillomavirus
HPV
intrinsic
42
Q

OPSCC

• 70% of all OPSCC associated with HPV – Mostly HPV____
• Incidence rate of HPV-OPSCC, particularly ____ cancer is ____
• Typically ____, white, < ____ years, no or little ____ exposure, higher
____ status
• Strong association between ____ contact and OPSCC

• Tobacco related cancers are decreasing, but oropharyngeal cancers are increasing
	○ Tonsillar cancer falls into category of oropharyngeal cancer - cells have limited resistance to HPV
• Unlike oral cancer:
	○ \_\_\_\_ patients
	○ Limited tobacco users/alcohol users
• More HPV subtypes than just 16 (18 is also common cancer causing virus)
A
16
tonsillar
increasing
male
60
tobacco
socioeconomic
oro-genital

younger

43
Q

HPV-OPSCC: Diagnosis
• ____ immunohistochemistry – Reliable surrogate for ____
• DNA in situ hybridization

	• Immunohistochemistry
		○ Antibody to p16 (cell cycle protein)
			§ A reliable surrogate of HPV infection
			§ \_\_\_\_% reliable
			§ Helps to guide therapy
A

p16
HPV
98

44
Q

• HPV has two proteins that are protooncogenes
○ E6
§ Inhibits ____
○ E7
§ Inhibits ____
○ ____ regulates RB; so if Rb is inactivated by virus, then p16 levels will increase dramatically

A

p53
Rb
p16

45
Q
Cancer therapeutics
• \_\_\_\_
– 1st line therapy
– < \_\_\_\_% survival for non-resectable tumors
• Radiation therapy 
• Chemotherapy
• If cannot excise cancer in entirety > significant risk for occurrence > poor survival rate
• Radiation therapy
	○ Mandatory for \_\_\_\_, may even occur before a surgery and they response very well
	○ May be \_\_\_\_ line, in addition to surgery
• Chemotherapy used for patients with high stage cancers with \_\_\_\_
	○ Rarely a \_\_\_\_ line therapy for cancer
A
surgery
25
HPV
first
metastasizes
first
46
Q

THE FUTURE IS NOW
• Current cancer diagnosis and therapy is based on a ____ approach

• Gene signatures distinguish ____ tumors (lymphomas, brain cancer,
breast cancer) from less aggressive ones

– Chemotherapies are ____-tailored based on these signatures

• Personalize treatments depending on the patient
	○ Based on actual sequencing of molecules expressed by cancers
• [NOTES]
A

molecular
aggressive
patient

47
Q

THE FUTURE IS NOW
• New technology has made it possible to identify a set of molecular changes and genomic signatures in the DNA of tumor cells that are distinct for tumor ____, that are not readily elucidated on the ____ level—and that can reveal a genetic blueprint of the patient’s tumor as discrete and singular as a fingerprint.

• Of all the tumor patients tested to date, approximately ____% of them have received genomic testing results that altered prognosis or empowered the treating oncologists to alter the patients’ treatment therapy or both.

A

subtypes
microscopic
75

48
Q

• Can’t use ____ cancer yet as a means to personalize therapy
○ Caused by a variety of molecular changes, some may/may not be prognostic

A

oral